NCT07720505

Brief Summary

COLOFLOW is a prospective observational study investigating whether Laser Speckle Contrast Imaging (LSCI), a dye-free and objective perfusion imaging technique, corresponds with the currently used subjective assessment of indocyanine green (ICG) fluorescence during colorectal surgery. In approximately 30 patients undergoing elective colon or rectal resection with primary anastomosis, both imaging modalities will be performed intraoperatively. The surgeons will base their clinical decisions solely on standard ICG fluorescence imaging, while LSCI measurements are collected for research purposes and do not influence treatment. Postoperatively, quantitative ICG parameters will be analysed and compared with LSCI perfusion maps to determine whether objective ICG analysis improves agreement with LSCI over subjective interpretation alone. In addition, the study will evaluate the feasibility of using the PerfusiX-IGS LSCI system during open colorectal surgery and describe postoperative outcomes, including anastomotic leakage. The ultimate goal is to contribute to more objective and standardized perfusion assessment during colorectal surgery

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
14mo left

Started Aug 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 22, 2026

Completed
10 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Last Updated

July 22, 2026

Status Verified

July 1, 2026

Enrollment Period

1 year

First QC Date

July 14, 2026

Last Update Submit

July 17, 2026

Conditions

Keywords

colonanastomosislaser speckle contrast imagingindocyanine greenICGNear-infrared

Outcome Measures

Primary Outcomes (1)

  • Agreement ICG vs LSCI

    the agreement between subjective ICG fluorescence assessment and LSCI perfusion imaging at the planned anastomotic site during colorectal surgery. This agreement will be evaluated in two ways: (1) categorical agreement, determining whether both techniques classify perfusion as adequate or inadequate, and (2) spatial agreement, assessing how closely the perfusion boundary identified by the surgeon using ICG corresponds to the perfusion boundary detected by LSCI.

    Periprocedural and day 0 (day of surgery)

Secondary Outcomes (3)

  • Spatial Agreement

    From surgery untill 30 days follow up

  • Feasibility Laser Speckle Device

    Peri-procedural (day 0)

  • 30-day postoperative clinical outcomes

    Day 0 untill 30-days post operatively

Interventions

Standard-of-care ICG fluorescence angiography for assessment of bowel perfusion and observational intraoperative Laser Speckle Contrast Imaging (LSCI) using the PerfusiX-IGS system. LSCI measurements do not influence surgical decision-making and are performed solely for comparison with subjective and quantitative ICG perfusion assessment.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The population for this study consists of adult patients undergoing elective colon or rectal resection with the creation of a primary anastomosis

You may qualify if:

  • Adults ≥18 years.
  • Undergoing elective colon resection with primary anastomosis.
  • Able to provide consent for postoperative analysis of intraoperative imaging

You may not qualify if:

  • Palliative surgery.
  • Factors that severely limit intraoperative visualization (per investigator judgement).
  • Conditions interfering with perfusion assessment (e.g., severe peripheral vascular compromise).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Wildeboer A, Heeman W, van der Bilt A, Hoff C, Calon J, Boerma EC, Al-Taher M, Bouvy N. Laparoscopic Laser Speckle Contrast Imaging Can Visualize Anastomotic Perfusion: A Demonstration in a Porcine Model. Life (Basel). 2022 Aug 16;12(8):1251. doi: 10.3390/life12081251.

    PMID: 36013430BACKGROUND
  • Heeman W, Wildeboer ACL, Al-Taher M, Calon JEM, Stassen LPS, Diana M, Derikx JPM, van Dam GM, Boerma EC, Bouvy ND. Experimental evaluation of laparoscopic laser speckle contrast imaging to visualize perfusion deficits during intestinal surgery. Surg Endosc. 2023 Feb;37(2):950-957. doi: 10.1007/s00464-022-09536-9. Epub 2022 Sep 6.

    PMID: 36068388BACKGROUND
  • De Nardi P, Elmore U, Maggi G, Maggiore R, Boni L, Cassinotti E, Fumagalli U, Gardani M, De Pascale S, Parise P, Vignali A, Rosati R. Intraoperative angiography with indocyanine green to assess anastomosis perfusion in patients undergoing laparoscopic colorectal resection: results of a multicenter randomized controlled trial. Surg Endosc. 2020 Jan;34(1):53-60. doi: 10.1007/s00464-019-06730-0. Epub 2019 Mar 21.

    PMID: 30903276BACKGROUND

MeSH Terms

Conditions

Anastomotic LeakColonic NeoplasmsRectal NeoplasmsRectal Diseases

Interventions

Laser Speckle Contrast Imaging

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Optical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Central Study Contacts

Indy Planting, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vascular surgeon

Study Record Dates

First Submitted

July 14, 2026

First Posted

July 22, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

September 30, 2027

Last Updated

July 22, 2026

Record last verified: 2026-07